ADST, SBSA, GLDN and GNTA are the Stocks to Watch for February 13th from OTCPicks.com
OTCPicks.com Presents Tomorrow’s Stock(s) to Watch: AdStar Inc. (OTC: ADST), Spanish Broadcasting System Inc. (NASDAQ: SBSA), Gold Dynamics Corp. (OTCBB: GLDN) and Genta Inc. (OTCBB: GNTA).
AdStar, Inc. provides technology services to the classified advertising industry in the United States. It offers services using its proprietary software that electronically connects advertisers with newspaper publishing systems, as well as online advertising formats. The company enables professional advertising agencies, businesses, and individuals to send ads to publishers electronically. Its services are provided on an application service provider (ASP) basis, enabling publishers to expand their relationships with advertising customers using a single integrated platform. The company's professional software applications accept transmissions from classified advertising agencies and corporations using desktop software and Web-based communications. Its ASP Web site technology enables visitors to a newspaper's Web site, giving the opportunity to buy classified ads, for both the print and/or online editions of the newspaper on a 24/7 basis. AdStar's XML Gateway technology allows third parties, internal newspaper applications, and Web publishers to facilitate the processing of classified advertising. In addition, the company, through its subsidiary, Edgil Associates, Inc., provides credit card processing services to the newspaper industry. Edgil offers system integration services, installation support, training, and customer service. Its software product, EdgCapture, allows publishers and groups of publishers to establish their own private payment processing interfaces. The company was founded in 1986 and is based in Marina del Rey, California.
SPANISH BROADCASTING SYSTEM INCORPORATED (NASDAQ: SBSA) "Up 8.73% on Friday"
Spanish Broadcasting System, Inc. is the largest publicly traded Hispanic-controlled media and entertainment company in the United States. SBS owns and/or operates 21 radio stations located in the top U.S. Hispanic markets of New York, Los Angeles, Miami, Chicago, San Francisco and Puerto Rico, airing the Tropical, Mexican Regional, Spanish Adult Contemporary and Hurban format genres. SBS operates 3 of the top 6 Spanish-language stations in the nation including the #1 Spanish station in America, WSKQ-FM in New York City. The Company also owns and operates MegaTV, a television operation with over-the-air, cable and satellite distribution and affiliates throughout the U.S. and Puerto Rico. SBS also produces live concerts and events and operates www.LaMusica.com, a bilingual Spanish-English online site providing content related to Latin music, entertainment, news and culture.
GOLD DYNAMICS CORPORATION (OTCBB: GLDN) "Up 57.45% on Friday"
Gold Dynamics Corp. is an emerging precious metal explorer focused on under-explored regions of the world that is seeking to grow shareholder value by building gold and silver mineral resources through systematic exploration. The company has brought together a highly experienced board and management team consisting of capable professionals with significant development and mine management experience.
GENTA INCORPORATED (OTCBB: GNTA) "Up 31.82% on Friday"
Genta Incorporated is a biopharmaceutical company with a diversified product portfolio that is focused on delivering innovative products for the treatment of patients with cancer. The Company is developing tesetaxel, a novel, orally absorbed taxane that is in the same class of drugs as paclitaxel and docetaxel. As the leading oral taxane in clinical development, tesetaxel has been evaluated in a broad program of completed or ongoing Phase 2a/Phase 2b clinical trials. The Company has announced that gastric (stomach) cancer will be the lead indication for Phase 3 registration studies. Genasense® (oblimersen sodium) Injection is a modified DNA-based antisense drug that may enhance the effectiveness of anticancer therapy. Genta has completed enrollment in a randomized, double-blind Phase 3 study of Genasense® in patients with advanced melanoma, known as “AGENDA”. Final data on survival and durable response from AGENDA, which may be pivotal for regulatory approval, are expected in the first half of 2011. Genta is exclusively marketing Ganite® (gallium nitrate injection) in the U.S., which is indicated for treatment of symptomatic patients with cancer-related hypercalcemia that is resistant to hydration. The Company has developed proprietary oral formulations of the active ingredient in Ganite® that are being evaluated as potential treatments for diseases associated with accelerated bone loss. Ganite® and Genasense® are available on a “named-patient” basis in countries outside the United States.
OTCPicks.com, one of the leading penny stock Web sites, presents its daily Stocks to Watch and Midday Market Movers every weekday. In addition to all the latest penny stock news, OTCPicks also offers daily newsletters, unique commentaries and free profiles, alerts and investing tips.
The stocks presented above are available in OTCPicks.com's Free Daily Email Newsletter. For daily stock alerts go to www.otcpicks.com to sign up.
Disclosure: OTCPicks.com and affiliates have been not been compensated by any of the companies covered in this release.
This is a press release. Press release distribution and press release services by EmailWire.Com: http://www.emailwire.com/us-press-release-distribution.php.